Martin Madden

Martin Madden

Lead Independent DirectoratNovoCure· In proxies 2023–2025

Martin Madden sits on 9 public boards.

Boards1

  • NovoCureLead independent director · 8 yr on the boardIndependentAudit, Compensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. NovoCurePublic company · 3 yr
    • Lead Independent Director2023 – Present · 3 yrStock in role -79%
  2. Microbot MedicalPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Director of Microbot Medical Inc. since 2017. Formerly a director of TSO3, Inc. (acquired by Stryker Corporation)Public company · 8 yr
    • Director2018 – Present · 8 yrNo stock prices for these years
  4. CordisPublic company
    • Director? – PresentNo stock prices for these years
  5. DePuy-SynthesPublic company
    • Director? – PresentNo stock prices for these years
  6. EthiconPublic company
    • Director? – PresentNo stock prices for these years
  7. Ethicon Endo-SurgeryPublic company
    • Director? – PresentNo stock prices for these years
  8. Johnson & Johnson’s Global Surgery GroupPublic company
    • Director? – PresentNo stock prices for these years
  9. TSO3, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?